Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Qualigen Therapeutics ( (QLGN) ).
Matt Korenberg resigned immediately as the chairman of the audit committee and independent member of Qualigen Therapeutics’ Board on October 3, 2024, with no disagreements cited regarding company operations or policies. Shortly after, on October 8, Braeden Lichti, an experienced entrepreneur with ties to several investment and advisory companies, was appointed as an independent member of the Board. Additionally, Robert Lim was named the new chairperson of the Audit Committee.
Learn more about QLGN stock on TipRanks’ Stock Analysis page.